Transform data into action
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more"We strive to help improve outcomes and create a healthier, more sustainable world for people everywhere.
LEARN MOREReimagine clinical development by intelligently connecting data, technology, and analytics to optimize your trials. The result? Faster decision making and reduced risk so you can deliver life-changing therapies faster.
Research & Development OverviewGenerate and disseminate evidence that answers crucial clinical, regulatory and commercial questions, enabling you to drive smarter decisions and meet your stakeholder needs with confidence.
REAL WORLD EVIDENCE OVERVIEWElevate commercial models with precision and speed using AI-driven analytics and technology that illuminate hidden insights in data.
COMMERCIALIZATION OVERVIEWOrchestrate your success across the complete compliance lifecycle with best-in-class services and solutions for safety, regulatory, quality and medical information.
COMPLIANCE OVERVIEWWhen your destination is a healthier world, making intelligent connections between data, technology, and services is your roadmap.
TECHNOLOGIES OVERVIEWExplore our library of insights, thought leadership, and the latest topics & trends in healthcare.
DISCOVER INSIGHTSAn in-depth exploration of the global healthcare ecosystem with timely research, insightful analysis, and scientific expertise.
SEE LATEST REPORTSBy making intelligent connections between your needs, our capabilities, and the healthcare ecosystem, we can help you be more agile, accelerate results, and improve patient outcomes.
LEARN MOREBuilding on a rich history of developing AI for healthcare, IQVIA AI connects the right data, technology, and expertise to address the unique needs of healthcare. It's what we call Healthcare-grade AI.
LEARN MOREYour new expert analyst is here. Be at the forefront of data-driven decision-making with a new generative AI tool that enables you to interact with our products and solutions like never before. Get results you can trust, faster.
LEARN MOREThe IQVIA Human Data Science Cloud is our unique capability designed to enable healthcare-grade analytics, tools, and data management solutions to deliver fit-for-purpose global data at scale.
LEARN MOREThe IQVIA Innovation Hub connects start-ups with the extensive IQVIA network of assets, resources, clients, and partners. Together, we can help lead the future of healthcare with the extensive IQVIA network of assets, resources, clients, and partners.
LEARN MOREIQVIA Decentralized Trials deliver purpose-built clinical services and technologies that engage the right patients wherever they are. Our hybrid and fully virtual solutions have been used more than any others.
LEARN MOREEmpowering patients to personalize their healthcare and connecting them to caregivers has the potential to change the care delivery paradigm.
LEARN MORE"At IQVIA your potential has no limits. We thrive on bold ideas and fearless innovation. Join us in reimagining what’s possible.
VIEW ROLESSocial Intelligence Report - Rheumatoid Arthritis. May, 2018 Edition. Social Intelligence reports are monthly syndicated publications covering one of four specific therapy areas. Each report covers the major pharmaceutical brands in a specific therapy area and monitors the brands over time to provide trend and competitive insights.
In the last five years, there have been 216 million conversations related to rheumatoid arthritis online and on social media. The active RA community online not only engages on social platforms to raise disease awareness, provide emotional support and discuss their disease experiences, but also voices their concerns, treatment-related unmet needs and expectations.
Foundations, advocacy groups, support organizations, patient communities and research groups are a few among the many to be mentioned who drive online conversations and digital initiatives in this area. The treatment landscape indicates that therapies in RA have mainly been aimed at reducing pain, stiffness and stopping the progression of joint destruction.
Most of the existing DMARD’s and biologics that have entered the market have been able to provide remarkable change in disease management and help patients experience longer periods of remission. While doctors often focus on treatment targets, for many patients, control over pain and fatigue, sustaining physical function and quality of life (QoL), is of primary importance.
Patients are commonly noted to express negative sentiment and specific concerns related to side effects while being on therapy that may impact their daily living. Such unmet needs related to their ability to regain function and achieve meaningful QoL could indeed reflect the growing dissatisfaction arising out of misaligned priorities between the patient and their healthcare partners. Thus, listening to the patient voice on social media becomes important as this can supplement interesting insights and create opportunities to markup the patient preferences to biologics therapy in this dynamic treatment landscape. This can also aid in improving patient-centered services.
To learn more about IQVIA Social Listening click here.
Transform data into action
Understand your performance...at a glance